6499 TWO Week ended 14 Aug 2026

Weekly Investor Report

Medeon Biodesign, Inc. · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 66.80 TWD
16.2% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -18.6% below the Trend Line and sits at 14.1% of its 52-week range. The latest completed week returned 16.2%, after a 3.4% four-week move. Near-term considerations: volume confirmation is below normal.

Setup score 19 out of 100
Latest Close 66.80 TWD 14 Aug 2026
1W Return 16.2% latest completed week
4W Return 3.4% short-term follow-through
12W Return -28.7% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 37.32% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 16.2% Latest completed week; four-week move 3.4%. Indicator stack 14/26 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.32% Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -18.6% below the Trend Line and sits at 14.1% of its 52-week range. The latest completed week returned 16.2%, after a 3.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0012-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.4% over four weeks, -28.7% over 12 weeks, and -34.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W16.2%
4W3.4%
12W-28.7%
26W-26.6%
52W-34.8%
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.36Latest activity-pressure read.
Pressure change12.7%Four-week change in activity pressure.
Leadership-48.19Latest relative-leadership reading.
RS change5.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment-

No current sentiment snapshot is stored.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.1%Distance below the 52-week high.
13-week volatility8.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+16.2%Week of 14 Aug.
Worst week-12.8%Week of 27 Mar.
Latest week+16.2%Week of 14 Aug.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses9
Sharp losses8
Recent vol8.1%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew7.3% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape17/100

Trend, activity pressure, participation, and risk combine to a 17/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.00; No reversal markers Next-Week ExpectancyNegative 37.32%

Next-week expectancy is negative with a 37.32% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

No sentiment snapshot is stored yet.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
14 Aug 202666.80 TWD16.2%82.09 TWD65.81 TWD-1.36-48.191.3MOff
7 Aug 202657.50 TWD0.7%82.99 TWD65.71 TWD-1.50-54.671.1MOff
31 Jul 202657.10 TWD-9.7%84.18 TWD65.69 TWD-1.50-54.952.1MOff
24 Jul 202663.20 TWD-2.2%85.59 TWD65.68 TWD-1.55-51.901.1MOff
17 Jul 202664.60 TWD-9.0%86.53 TWD65.62 TWD-1.56-50.871.8MOff
10 Jul 202671.00 TWD-2.5%87.53 TWD65.56 TWD-1.58-50.47877.2KOff
3 Jul 202672.80 TWD7.1%88.32 TWD65.46 TWD-1.50-52.081.5MOff
26 Jun 202668.00 TWD-7.7%89.13 TWD65.34 TWD-1.32-54.131.8MOff
19 Jun 202673.70 TWD-1.1%89.91 TWD65.25 TWD-1.08-53.441.0MOff
12 Jun 202674.50 TWD-9.0%90.67 TWD65.12 TWD-0.63-51.432.6MOff
5 Jun 202681.90 TWD-3.6%91.42 TWD64.99 TWD-0.62-48.612.1MOff
29 May 202685.00 TWD-9.3%92.18 TWD64.80 TWD-0.68-47.263.5MOff
22 May 202693.70 TWD12.1%93.11 TWD64.60 TWD-0.78-39.616.4MOff
15 May 202683.60 TWD1.0%94.16 TWD64.35 TWD-1.08-45.112.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context